Market Research Logo

Global Chemiluminescence Analyzer (CLA) Market 2017-2021

Global Chemiluminescence Analyzer (CLA) Market 2017-2021

About Chemiluminescence Analyzer (CLA)

A chemiluminescence analyzer can be defined as a device that detects radiation or light produced in a chemical reaction when a chemical entity returns from an electronic excited state to its stable form. This excitation is achieved through oxidation or chemical catalysis. In vitro diagnostic (IVD) devices are medical devices that are used to perform tests on samples such as blood or urine to diagnose medical conditions and prevent chronic diseases.

Technavio’s analysts forecast the global chemiluminescence analyzer market to grow at a CAGR of 6.41% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global chemiluminescence analyzer market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of CLAs to the various end-users.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Chemiluminescence Analyzer Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • Beckman Coulter
  • bioMérieux SA
  • F. Hoffmann-La Roche
  • Siemens Healthineers
Other prominent vendors
  • Biokit
  • DiaSorin
  • Ortho Clinical Diagnostics
Market driver
  • Predictive and preventive medicine for early diagnosis and treatment
  • For a full, detailed list, view our report
Market challenge
  • Lack of accessibility and affordability of diagnostic tests in developing countries
  • For a full, detailed list, view our report
Market trend
  • Adoption of standardization and automation across the in vitro diagnostics industry
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Chemiluminescence Analyzer (CLA) Market 2017-2021

Technavio recognizes the following companies as the key players in the global chemiluminescence analyzer market: Abbott Laboratories, Beckman Coulter, bioMérieux SA, F. Hoffmann-La Roche, and Siemens Healthineers.

Other Prominent Vendors in the market are: Biokit, DiaSorin, and Ortho Clinical Diagnostics.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is adoption of standardization and automation across the in vitro diagnostics industry. Due to the cost cutting in clinical lab fees, profitability, per test, is decreasing, which makes it necessary for the laboratories to focus on volume rather than value. There is also heavy pressure for quality, error-free results.”

According to the report, one driver in the market is predictive and preventive medicine for early diagnosis and treatment. Globally, there is a trend in the world of medicine to transform from reactive healthcare to preventive healthcare. The changes as part of this trend will be propelled by new approaches to disease that will trigger the emergence of predictive and preventive medicine ultimately leading to personalized medicinal procedures.

Further, the report states that one challenge in the market is lack of accessibility and affordability of diagnostic tests in developing countries. High-quality diagnostic tests are easily available for various diseases in the majority of the developed countries however, they are neither affordable nor accessible in developing countries, where disease burden is high. Management of disease by addressing symptoms is ineffective and increases the risk of antibiotic resistance.



Companies Mentioned

Abbott Laboratories, Beckman Coulter, bioMérieux SA, F. Hoffmann-La Roche, Siemens Healthineers, Biokit, DiaSorin, and Ortho Clinical Diagnostics.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Applications of IVDs
  • Market landscape
    • Market overview
      • Table Global CLA market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product type
    • Market overview
      • Table Global CLA market by product type 2016 and 2021
      • Table Global benchtop CLA market 2016-2021 ($ millions)
      • Table Global floor-standing CLA market 2016-2021 ($ millions)
  • Market segmentation by end-user
    • Market overview
      • Table Global CLA market by end-users 2016 and 2021
      • Table Global CLA market by hospitals and diagnostic centers 2016-2021 ($ millions)
      • Table Advantages of CLAs for hospitals and diagnostic centers
      • Table Global CLA market by research laboratories 2016-2021 ($ millions)
      • Table Global CLA market by pharma and biotech companies 2016-2021 ($ millions)
      • Table Global CLA market by academic research centers 2016-2021 ($ millions)
  • Geographical segmentation
    • Market Overview
      • Table Global CLA market by geography 2016 and 2021
    • CLA market in EMEA
      • Table CLA market in EMEA 2016-2021 ($ millions)
    • CLA market in Americas
      • Table CLA market in Americas 2016-2021 ($ millions)
      • Table Market facts highlighting the increase in personalized medicine
      • Table Share of personalized medicines across different disease areas
    • CLA market in APAC
      • Table CLA market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Advantages of disease diagnosis
      • Table Advantages of predictive and preventive medicine
      • Table Importance of diagnostics in identifying correct respondents for correct therapy
      • Table Advantages of CLIA over ELISA
    • Market challenges
      • Table Barriers for diagnostics market in developing countries
  • Market trends
  • Vendor landscape
    • Competitive scenario
      • Table Strategic success factors for companies
  • Key vendor analysis
    • Abbott Laboratories
      • Table Abbott Laboratories: Profile
      • Table Abbott Laboratories: Strength analysis
      • Table Abbott Laboratories: Strategy assessment
      • Table Abbott Laboratories: Opportunity assessment
    • Beckman Coulter
      • Table Beckman Coulter: Profile
      • Table Beckman Coulter: Strength analysis
      • Table Beckman Coulter: Strategy assessment
      • Table Beckman Coulter: Opportunity assessment
    • bioMérieux SA
      • Table bioMérieux: Profile
      • Table bioMérieux: Strength analysis
      • Table bioMérieux: Strategy assessment
      • Table bioMérieux: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Profile
      • Table F. Hoffmann-La Roche: Strength analysis
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Siemens Healthineers
      • Table Siemens Healthineers: Profile
      • Table Siemens Healthineers: Strength analysis
      • Table Siemens Healthineers: Strategy assessment
      • Table Siemens Healthineers: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report